The edible vaccine market has shown strong growth, rising from $8.04 billion in 2023 to $8.77 billion in 2024 at a CAGR of 9.1%. Key factors include advancements in genetic engineering, limitations of traditional vaccines, biopharming advancements, emphasis on global immunization, and increased government support.
The edible vaccine market is projected to grow strongly, reaching $12.50 billion by 2028 at a CAGR of 9.2%. Growth drivers include pandemic preparedness, advancements in plant biotechnology, public acceptance of genetically modified foods, cold chain challenges, and food security integration. Trends include expansion into animal health, biopharming use, personalized nutrition and vaccination, sustainability, and the development of multi-antigen edible vaccines.
Major Driver In The Edible Vaccine Market
The increasing prevalence of infectious diseases is expected to propel the growth of the edible vaccine market. Infectious diseases are rising due to factors such as globalization, climate change, urbanization, and antibiotic resistance. Edible vaccines, which stimulate immune responses by consuming genetically modified foods that produce antigens, offer a cost-effective and needle-free method of immunization. In March 2024, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases, with the rate per 100,000 people rising from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the edible vaccine market.
Request A Free Sample Of The Edible Vaccine Market Report
Edible Vaccine Market Competitive Landscape
Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation
Key Edible Vaccine Market Trend
Companies in the edible vaccine market are focusing on developing innovative solutions such as oral cholera vaccines to address global health challenges. For instance, in August 2024, Bharat Biotech launched Hillchol, an oral cholera vaccine that provides long-lasting immunity with a single dose, offering protection against cholera while being easy to administer and not requiring cold storage.
Purchase The Global Edible Vaccine Market Report Directly And Get A Swift Delivery
Global Edible Vaccine Market Segmentation
The edible vaccine market covered in this report is segmented –
1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals
By Geography:The regions covered in the edible vaccine market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the edible vaccine market in 2023.
The Edible Vaccine Global Market Report 2024 furnishes information about the global edible vaccine market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
